Form 8-K - Current report:
SEC Accession No. 0001104659-18-039068
Filing Date
2018-06-08
Accepted
2018-06-08 08:34:17
Documents
5
Period of Report
2018-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-15070_18k.htm 8-K 59114
2 EX-3.1 a18-15070_1ex3d1.htm EX-3.1 10189
3 EX-10.1 a18-15070_1ex10d1.htm EX-10.1 119041
4 EX-99.1 a18-15070_1ex99d1.htm EX-99.1 9741
5 GRAPHIC g150701mmi001.jpg GRAPHIC 3278
  Complete submission text file 0001104659-18-039068.txt   204132
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 18888131
SIC: 2834 Pharmaceutical Preparations